Comparison of daily and monthly pyrantel treatment in yearling thoroughbreds and the protective effect of strategic medication of mares on their foals.
Studies on a Thoroughbred breeding farm in Ohio were done to: (1) compare the effects of daily administration of pyrantel tartrate feed pellets with monthly administration of a pyrantel pamoate paste to yearling horses (21 January-3 September); (2) assess the effects of daily pyrantel tartrate given strategically in spring/summer to foaling mares (1 April-16 August) and given for a prolonged period to barren mares (21 January-3 September); (3) determine if strategic medication of foaling mares with daily pyrantel tartrate protected their foals until weaning. There were no differences in cyathostome egg counts, pasture larval counts, body condition scores, or body weights of yearlings treated with daily pyrantel tartrate or monthly pyrantel pamoate. Both treatments failed to maintain fecal egg counts of yearlings below 100 eggs per gram (epg), and mean counts exceeded 400 epg (pyrantel pamoate) and 700 epg (pyrantel tartrate) in August and September, resulting in a sharp, but moderate increase in pasture infectivity in October. By contrast, prolonged or strategic use of daily pyrantel tartrate in mature horses were each highly effective in reducing pasture contamination and infectivity with cyathostome eggs and larvae respectively. Strategic medication of foaling mares provided protection of their foals until weaning and first treatment of foals was delayed until after weaning when mean strongyle counts exceeded 100 epg. Treatment of weanlings with pyrantel pamoate had little effect on egg counts. A comparative anthelmintic study with ivermectin, oxibendazole, and pyrantel pamoate confirmed earlier studies showing reduced efficacy of anthelmintics in young horses.
Herd
R P
RP
Department of Veterinary Preventive Medicine, Ohio State University, Columbus 43210.
Majewski
G A
GA
D000284:Administration, Oral; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006373:Helminthiasis / Q000517:prevention & control; D006374:Helminthiasis, Animal; D006734:Horse Diseases; D006736:Horses; D007559:Ivermectin / Q000627:therapeutic use; D010270:Parasite Egg Count; D011716:Pyrantel Pamoate / Q000008:administration & dosage / Q000627:therapeutic use*; D011717:Pyrantel Tartrate / Q000008:administration & dosage / Q000627:therapeutic use*; D012621:Seasons
D000871:Anthelmintics; D001562:Benzimidazoles; C011321:oxibendazole; D007559:Ivermectin; D011716:Pyrantel Pamoate; D011717:Pyrantel Tartrate